Journey Medical (DERM) Research & Development (2021 - 2026)
Journey Medical's (DERM) quarterly Research & Development came in at $154000.0 in Q4 2025, down 29.36% YoY from $218000.0 in Q4 2024, and down 46.34% on a QoQ basis from $287000.0 in Q3 2025.
Journey Medical (DERM) Research & Development (2021 - 2026) Analysis & Trends
Journey Medical (DERM) has 5 years of Research & Development data on file, last reported at $154000.0 in Q4 2025.
- Quarterly Research & Development fell 29.36% year-over-year to $154000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $480000.0 (down 95.13% YoY) and the FY2025 annual result came in at $480000.0, down 95.13% from the prior year.
- Research & Development declined to $154000.0 in Q4 2025, from $287000.0 in the prior quarter.
- In the past five years, Research & Development ranged from a high of $7.9 million in Q1 2024 to a low of $29000.0 in Q2 2021.
- A 5-year average of $1.8 million and a median of $1.4 million in 2022 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2022 — Research & Development jumped 8896.55% — and 2025, when it tumbled 99.51%.
- Tracing DERM's Research & Development over 5 years: stood at $2.0 million in 2021, then jumped by 113.65% to $4.3 million in 2022, then sank by 64.64% to $1.5 million in 2023, then tumbled by 85.51% to $218000.0 in 2024, then retreated by 29.36% to $154000.0 in 2025.
- The last three Research & Development figures came in at $154000.0 (Q4 2025), $287000.0 (Q3 2025), and $39000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | 970.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -1.05 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 146.30 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 248.30 Mn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 326.70 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 92.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Journey Medical | 208.13 Mn | 182.48 Mn | 12.37 Mn | 54,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 54,000.00 |
| Dec 31, 2025 | 154,000.00 |
| Sep 30, 2025 | 287,000.00 |
| Mar 31, 2025 | 39,000.00 |
| Dec 31, 2024 | 218,000.00 |
| Sep 30, 2024 | 842,000.00 |
| Jun 30, 2024 | 913,000.00 |
| Mar 31, 2024 | 7.88 Mn |
| Dec 31, 2023 | 1.51 Mn |
| Sep 30, 2023 | 2.23 Mn |
| Jun 30, 2023 | 1.77 Mn |
| Mar 31, 2023 | 2.03 Mn |
| Dec 31, 2022 | 4.26 Mn |
| Sep 30, 2022 | 2.81 Mn |
| Jun 30, 2022 | 2.61 Mn |
| Mar 31, 2022 | 1.27 Mn |
| Dec 31, 2021 | 1.99 Mn |
| Sep 30, 2021 | 718,000.00 |
| Jun 30, 2021 | 29,000.00 |